BACKGROUND: No study has compared the bothersomeness of all lower urinary tract symptoms (LUTS) using a population-based sample of adults. Despite this lack of evidence, investigators have often cited their LUTS of interest as the "most bothersome" or "one of the most bothersome."
OBJECTIVE: To compare the population- and individual-level burden of LUTS in men and women.
DESIGN, SETTING, AND PARTICIPANTS: In this population-based cross-sectional study, questionnaires were mailed to 6000 individuals (18-79 yr of age) randomly identified from the Finnish Population Register.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The validated Danish Prostatic Symptom Score questionnaire was used for assessment of bother of 12 different LUTS. The age-standardized prevalence of at least moderate bother was calculated for each symptom (population-level burden). Among symptomatic individuals, the proportion of affected individuals with at least moderate bother was calculated for each symptom (individual-level bother).
RESULTS AND LIMITATIONS: A total of 3727 individuals (62.4%) participated (53.7% female). The LUTS with the greatest population-level burden were urgency (7.9% with at least moderate bother), stress urinary incontinence (SUI) (6.5%), nocturia (6.0%), postmicturition dribble (5.8%), and urgency urinary incontinence (UUI) (5.0%). Burden from incontinence symptoms was higher in women than men, and the opposite was true for voiding and postmicturition symptoms. At the individual level, UUI was the most bothersome for both genders. Although the response proportion was high, approximately a third did not participate.
CONCLUSIONS: Both men and women with UUI report moderate or major bother more frequently than individuals with other LUTS. At the population level, the most prevalent bothersome symptoms are urgency, SUI, and nocturia.
PATIENT SUMMARY: Urinary urgency was the most common troubling symptom in a large population-based study; however, for individuals, urgency incontinence was the most likely to be rated as bothersome.
Written by:
Agarwal A, Eryuzlu LN, Cartwright R, Thorlund K, Tammela TL, Guyatt GH, Auvinen A, Tikkinen KA. Are you the author?
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada; Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Department of Epidemiology and Biostatistics, Imperial College London, London, UK; Department of Urogynaecology, St. Mary's Hospital, London, UK; Stanford Prevention Research Center, Stanford University, Stanford, CA, USA; Department of Urology and School of Medicine, Tampere University Hospital and University of Tampere, Tampere, Finland; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; School of Public Health, University of Tampere, Tampere, Finland; Department of Urology, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.
Reference: Eur Urol. 2014 Jan 24. pii: S0302-2838(14)00070-0.
doi: 10.1016/j.eururo.2014.01.019
PubMed Abstract
PMID: 24486308
Go "Beyond the Abstract" - Read an article written by the authors for UroToday.com
UroToday.com Overactive Bladder (OAB) Section
